Endogenous superantigen-mediated thymic negative selection resulted in a paucity of mature T cells bearing T-cell receptor (TCR) V␤8 in the periphery. Consequently, the magnitude of immune response to exogenous superantigen staphylococcal enterotoxin B, which activates TCR V␤8 ؉ T cells, was significantly reduced and conferred protection from superantigen-induced mortality.
Superantigens are a family of microbial proteins that bind directly to major histocompatibility complex (MHC) class II molecules outside of the peptide-binding groove and activate CD4 ϩ and CD8 ϩ T cells expressing certain T-cell receptor (TCR) V␤ families (10) . Superantigens encoded by retroviruses integrated into the genome are called "endogenous superantigens," and those of bacterial origin are called "exogenous superantigens" (3) . The outcome of superantigen-mediated activation differs for mature T cells and immature thymocytes. While the former proliferate vigorously, the latter rapidly undergo apoptosis. Therefore, thymic expression of endogenous superantigens encoded by integrated retrovirus transmitted through the germ line causes deletion of thymocytes bearing certain TCR V␤ families, resulting in a paucity of those TCR V␤ families in the mature peripheral T-cell pool (13) .
Endogenous superantigen-mediated TCR V␤ deletions are reported in humans (8) . HERV-K18, a human endogenous retrovirus-encoded superantigen, can cause deletion of TCR V␤7 ϩ thymocytes (7). Incidentally, TCR V␤7-bearing T cells are strongly stimulated by the exogenous superantigen staphylococcal enterotoxin A (SEA) in humans (10) . Individuals expressing HERV-K18 in the thymus would theoretically mount a poor immune response to SEA due to a dearth of mature TCR V␤7 ϩ T cells in the periphery and thus could be protected from SEA-induced toxic shock syndrome. Due to the extreme toxicity of bacterial superantigens to humans, we tested the hypothesis that endogenous superantigen-mediated TCR V␤ deletions can modulate the immune response elicited by an exogenous bacterial superantigen using the well-established HLA class II transgenic mouse model (2, 11, 14, 15) .
We have generated two independent lines of HLA class II transgenic mice expressing HLA-DR3 (DRB1*0301) (12) and HLA-DR2 (DRB1*1501) (1). These two HLA-DR alleles share the same DR␣ chain, DRA*0103. Previous studies have shown that expression of transgenic class II molecules in these mice is comparable with murine MHC class II molecules. However, it should be noted that these mice completely lack all endogenous MHC class II genes (6) , and the T-cell responses are restricted only by the transgenic HLA class II (1) . While the levels of expression of transgenic class II (Fig. 1A) and distribution of CD4 ϩ and CD8 ϩ T cells (Fig. 1B) are comparable between these lines, the presence of some endogenous superantigen in the DR2 lines deleted CD4 ϩ as well as CD8 (Fig. 3) . Since this deletion is MHC class II dependent and occurs in both CD4 ϩ and CD8 ϩ T cells during transition from the double-positive (DP) to the single-positive stage in thymus, we conclude that this deletion is mediated by endogenous superantigen.
It is very well established that staphylococcal enterotoxin B (SEB) activates CD4 and CD8 T cells bearing TCR V␤8 in mice (5, 11, 12) . Since HLA-DR2 mice but not HLA-DR3 mice delete CD4 ϩ and CD8 ϩ T cells bearing TCR V␤8, this would be an excellent model to study the in vivo effects of endogenous superantigen-mediated TCR V␤ deletion on the immune response to an exogenous superantigen.
Contrary to the expectation that the absence of TCR V␤8-bearing T cells in HLA-DR2 mice would result in substantial reduction in SEB-induced immune activation, we observed that splenocytes from HLA-DR2 mice showed a strong in vitro T-cell response to SEB, albeit lesser than DR3 mice (Fig. 4) . To gain a better insight into this process, HLA-DR3 and HLA-DR2 mice were challenged in vivo with purified SEB and the TCR V␤ usage was determined by flow cytometry 3 days later. In HLA-DR3 transgenic mice, as shown by us earlier, TCR V␤8 ϩ T cells increased in both CD4 ϩ and CD8 ϩ subsets (Fig.  5) . However, in HLA-DR2 transgenic mice, since TCR V␤8-bearing T cells are deleted, they did not contribute much to the peripheral T-cell pool. However, T cells bearing TCR V␤7 expanded by nearly 10-fold in both CD8 ϩ and CD4 ϩ T-cell populations. In addition, T cells bearing TCR V␤14, which did not respond in DR3 mice, expanded significantly in response to SEB in DR2 mice. Together, TCR V␤7 and V␤14 contributed to 55 to 60% of the T-cell pool following SEB injection, whereas they contributed to less than 25% of the CD4 ϩ and CD8 ϩ T-cell pool in naive mice. Similar results were obtained with another DR2 transgenic line expressing the same DR␣ chain but a different DR␤ chain (DRB*1502), which also shows TCR V␤8 family deletion (data not shown).
We next studied the extent of thymocyte deletion in SEBtreated mice. Whereas the peripheral T cells undergo expansion, the CD4 CD8 DP thymocytes undergo deletion following in vivo challenge with SEB (4). While there was a dramatic reduction in DP thymocytes in SEB-treated DR3 mice, DR2 mice had only minimal reduction in DP thymocyte subsets (Fig. 6) . We also measured serum cytokine levels in these mice following SEB challenge (Table 1) . While SEB-challenged HLA-DR3 mice had a dramatic increase in various proinflammatory cytokines in the serum as early as 4 h, neither DRB*1501 nor DRB*1502 mice showed such a change in serum cytokine profile after SEB challenge. In addition, while about 80% (8/10) of the DR3 mice succumbed to SEB-induced mortality during the study, none of the DR2 (DR*1501 or DR*1502) mice died (0/3 in each group).
In conclusion, we have shown for the first time that the immune response to exogenous superantigen that preferentially activates T cells bearing TCR V␤ families deleted by endogenous superantigen is significantly reduced to the extent of conferring protection from exogenous superantigen-mediated mortality. Endogenous superantigens could thus have clinical implications other than autoimmunity (9) . Further, in the absence of T cells bearing the high-affinity TCR V␤ specific for a given exogenous superantigen (V␤8 in this case), T cells bearing low-affinity TCR V␤ families (V␤7 and V␤14 in this case) can compensate to a certain extent. FIG. 6 . SEB-induced thymic deletion in HLA-DR transgenic mice. Thymocytes from age-matched HLA-DR3 and -DR2 transgenic mice (n ϭ 3 to 10 mice/group) challenged with 10 g of SEB 3 days earlier were stained for CD4 as well as CD8 and analyzed by flow cytometry. Shown are the reductions in single-positive (SP) and DP thymocyte subsets. a HLA-DR3; HLA-DR2 (1501), and HLA-DR2 (1502) mice (n Ն 3/group) were challenged with either 10 g of SEB or phosphate-buffered saline (PBS) alone by intraperitoneal injection. Mice were bled 4 h later, and levels of indicated cytokines in sera were determined by cytometric bead assay (BD Biosciences, San Diego, CA) as per manufacturer's instructions. PBS-challenged mice had negligible amounts of cytokines in the serum and hence are not shown. IL-12p70, interleukin-12p70; TNF-␣, tumor necrosis factor alpha; IFN-␥, gamma interferon; MCP-1, monocyte chemoattractant protein-1. 
